阿里硫酶K通过调节帕金介导的线粒细胞衰老来减弱COPD中的呼吸道上皮细胞衰老
Ruonan Yang1, Yuan Zhan2, Zhesong Deng1
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
Redox biology
|August 5, 2025
概括
阿里硫酶X (ARSK) 保护慢性阻塞性肺病 (COPD) 中的细胞衰老. 恢复ARSK功能可能为COPD患者提供新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子遗传学 分子遗传学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及不可逆转的空气流量限制,通常是由香烟烟雾 (CS) 引起的.
- 细胞衰老越来越被认为是COPD发展的关键因素.
- 阿里硫酶家族在COPD中的作用在很大程度上仍未被探索.
研究的目的:
- 调查酸硫酸酶家族,特别是ARSK在COPD病变发生过程中的作用.
- 阐明ARSK影响CS诱导的细胞衰老和肺功能的分子机制.
主要方法:
- 在COPD患者肺组织中ARSK表达的生物信息学分析和临床验证.
- 在体外实验中评估ARSK过度表达和对CS诱导的上皮衰老,线粒细胞衰变和线粒体功能的击倒的影响.
- 在CS暴露模型中使用腺相关病毒 (AAV) 介导的基因传递和气道特异性基因淘汰的体内研究.
- 涉及ARSK-帕金 (PRKN) 相互作用和雄激素受体 (AR) 结合试验的机制研究.
主要成果:
- 慢性肺炎患者的ARSK表达显著降低,特别是在呼吸道上皮.
- 过度表达ARSK减弱了CS诱导的上皮衰老,增强了线粒体和改善了线粒体功能.
- 阿尔斯克敲击加剧了CS诱导的肺衰老和功能障碍.
- ARSK与PRKN相互作用,调节菌和减弱衰老;AR被确定为ARSK表达的调节者.
结论:
- 在COPD中,ARSK对香烟烟雾引起的上皮细胞衰老起着保护作用.
- 通过与PRKN的相互作用,ARSK调节了线粒体和线粒体功能.
- ARSK代表了缓解COPD进展的潜在治疗目标.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
525
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
525
Cystic Fibrosis: Management
224
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
224
COPD: Management Using Bronchodilators and Corticosteroids
312
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
312
Cystic Fibrosis: Pathogenesis
364
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
364
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K


